Back to Agenda
Medicine Supply Resilience: Experiences from Chinese Taipei
Session Chair(s)
Chih-Kang Chiang, MD
Director General, TFDA, Chinese Taipei, Taiwan
This session explores medicine supply resilience through the experience of Chinese Taipei. Experts from industry, healthcare organizations, and regulatory authorities will exchange perspectives with counterparts from the EU, Japan, and the United States on strengthening global coordination for critical medicines.
Learning Objective : This session will examine how Chinese Taipei has advanced from managing medicine shortages to building broader supply resilience. Drawing on perspectives from regulators, industry, and healthcare organizations, and experiences from the EU, Japan, and the United States, participants will explore critical medicines, international collaboration, and practical approaches to strengthening resilient supply frameworks and cross-regional partnerships.
Speaker(s)
Academic Perspectives on Strengthening Medicine Supply Resilience
Lawrence Eugene Liberti, RAC
Director, D.K. Kim International Center for Regulatory Science, The Kim Center/ USC DRQS, United States
From Shortage Management to Resilience Governance: Taiwan’s Evolving Policy Approach
Representative Invited
Director General, TFDA, Chinese Taipei, Taiwan
From Regulation to Resilience: Taiwan’s Strategy in Controlled Drug Manufacturing and Future Directions
Meng-Hsiu Wu, MS
Deputy Director, Division of Medicinal Products, TFDA, Chinese Taipei, Taiwan
Lessons from Japan: Projects for Enhanced Supply Resilience
Masaya Tamae
Deputy General Manager, Corporate Strategy Division, Meiji Seika Pharma., Co., Ltd, Japan
From Shortage to Resilience: Building Medication Supply Preparedness in Health Systems
Matthew Eberts, PharmD, MBA, MHA
Senior Director System Pharmacy Business and Outcomes, University of Maryland Medical System, United States
Have an account?